Clotting abnormalities in critically ill COVID-19 patients are inconsistent with overt disseminated intravascular coagulation

The SARS-CoV-2 is a coronavirus causing a human infection designated as COVID-19 by the World Health Organization. Up to 5% of symptomatic patients are admitted to intensive care unit (ICU) for acute respiratory distress syndrome (ARDS), sepsis and multiple organ failure. Clotting abnormalities have been documented in COVID-19 patients [1], eventually culminating in DIC in patients with poor prognosis [2]. However, the occurrence of consumption coagulopathy has been questioned by some reports [3,4].
Source: Thrombosis Research - Category: Hematology Authors: Tags: Letter to the Editors-in-Chief Source Type: research